The Directorate General of Trade Remedies (DGTR) on September 17, 2026, issued a notification regarding an anti-dumping investigation concerning imports of “Ethambutol Hydrochloride” originating in or exported from the People’s Republic of China and the Kingdom of Thailand.
The following has been stated: -
•The Designated Authority initiated an anti-dumping investigation into imports of Ethambutol Hydrochloride from China PR and Thailand based on an application filed by Lupin Limited, with the period of investigation covering April 01, 2024 to March 31, 2025.
•The Authority found that the subject imports were dumped at significant margins and had caused material injury to the domestic industry through increased imports, price undercutting, price suppression, reduced market share, idle capacity, and financial losses.
•It concluded that the injury was attributable to the dumped imports and that there was no demand-supply gap in India.
•The Authority also noted the public interest in maintaining diversified sources of supply, as Ethambutol Hydrochloride is used in the manufacture of anti-tuberculosis medicines.
The detailed notification is given in the document below.
[Notification No.: Case No. AD (OI)-22/2025]
